Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Enfortumab Vedotin
Related studies linked through entity extraction aliases.
Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing
- Status
- RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis
- Status
- RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE)
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection
- Status
- RECRUITING
- Phase
- N/A
Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
- Status
- RECRUITING
- Phase
- PHASE2
Renal Retention in High Grade Upper Tract Urothelial Cancer
- Status
- RECRUITING
- Phase
- PHASE2
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
- Status
- COMPLETED
- Phase
- PHASE1
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
StrataPATHâ„¢ (Precision Indications for Approved Therapies)
- Status
- TERMINATED
- Phase
- PHASE2